The Economic Times daily newspaper is available online now.

    Rekha Jhunjhunwala picks 2% stake in smallcap pharma stock

    Synopsis

    Sun Pharma Advanced Research Company (SPARC) is a clinical-stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. SPARC was formed in 2007 following its demerger from Sun Pharma, a global leader in speciality generics.

    Rekha Jhunjhunwala picks 2% stake in smallcap pharma stock
    Investor Rekha Jhunjhunwala, wife of ace late investor Rakesh Jhunjhunwala, picked a stake in smallcap Sun Pharma Advanced Research Company in the December quarter. As per the latest shareholding data filed by the company, the investor at the end of the December quarter held 62,92,134 equity shares or 1.94% stake in the firm.

    The latest corporate shareholdings filed suggest that Jhunjhunwala publicly holds 21 stocks with an estimated net worth of over Rs 20,097.7 crore.

    In the December quarter of 2022, she also added stakes in counters such as Geojit Financial, Aptech, Canara Bank and NCC. Other stocks in her portfolio include Singer India, Agro Tech Foods, Crisil, DB Realty, Jubilant Pharmova, Star Health and Jubilant Ingrevia.

    Sun Pharma Advanced Research Company is an underperforming stock with a negative return of 35% in the last one year. The stock in the past six months has generated a negative return of 5%.

    At 10.50 am, the stock was trading 1.3% higher at Rs 209.6. Meanwhile, the stock is up 22% from its 52-week low. The stock’s 52-week low and high prices are Rs 172.45 and Rs 348.75 per share, respectively.

    Technically, the stock is trading below 5 out of 8 SMAs (Simple Moving Average). The stock is trading below 30-day, 50-day, 100-day, 150-day and 200-day moving averages but is above 5-day, 10-day and 20-day moving averages.

    After the decline in FII shareholding seen for the last few quarters in the counter, there has been an increase in FII stake to 3.54% during the December quarter from 2.38% in the September quarter.

    Sun Pharma Advanced Research Company (SPARC) is a clinical-stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. SPARC was formed in 2007 following its demerger from Sun Pharma, a global leader in speciality generics.

    (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)



    (What's moving Sensex and Nifty Track latest market news, stock tips and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.

    Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

    ...more
    The Economic Times

    Stories you might be interested in